201 related articles for article (PubMed ID: 37284062)
1. Development and validation of an immune infiltration/tumor proliferation-related Notch3 nomogram for predicting survival in patients with primary glioblastoma.
Zheng ZQ; Zhang GG; Yuan GQ; Hao JH; Nie QQ; Zheng MC; Wang Z
Front Genet; 2023; 14():1148126. PubMed ID: 37284062
[No Abstract] [Full Text] [Related]
2. Chromobox 7/8 serve as independent indicators for glioblastoma
Zheng ZQ; Yuan GQ; Kang NL; Nie QQ; Zhang GG; Wang Z
Front Neurol; 2022; 13():912039. PubMed ID: 36034290
[TBL] [Abstract][Full Text] [Related]
3. Development and Validation of CXCR4 Nomogram-Based Immune Infiltration/Tumor Inflammation in Primary Glioblastoma.
Jiang G; Zheng ZQ; Zhang J; Tian Z; Li X; Yu Z; Wang Z; You W; Chen G
Brain Sci; 2023 Aug; 13(8):. PubMed ID: 37626511
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a predictive model in diagnosis and prognosis of primary glioblastoma patients based on Homeobox A family.
Zheng ZQ; Yuan GQ; Zhang GG; Nie QQ; Wang Z
Discov Oncol; 2023 Jun; 14(1):108. PubMed ID: 37351805
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of an inflammatory response-related prognostic model and immune infiltration analysis in glioblastoma.
Zhu W; Luo N; Li Q; Chen X; Li X; Fu M; Yang F; Chen Z; Zhang Y; Zhang Y; Peng X; Hu G
Ann Transl Med; 2023 Jan; 11(2):69. PubMed ID: 36819551
[TBL] [Abstract][Full Text] [Related]
6. AEBP1 as a potential immune-related prognostic biomarker in glioblastoma: a bioinformatic analyses.
Liu M; Yu Y; Zhang Z; Chen Z; Chen B; Cheng Y; Wei Y; Li J; Shang H
Ann Transl Med; 2021 Nov; 9(22):1657. PubMed ID: 34988166
[TBL] [Abstract][Full Text] [Related]
7. A new prognostic model for glioblastoma multiforme based on coagulation-related genes.
Zhou M; Deng Y; Fu Y; Liang R; Liu Y; Liao Q
Transl Cancer Res; 2023 Oct; 12(10):2898-2910. PubMed ID: 37969372
[TBL] [Abstract][Full Text] [Related]
8. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
[TBL] [Abstract][Full Text] [Related]
9. Bioinformatic analyses reveal a distinct Notch activation induced by STAT3 phosphorylation in the mesenchymal subtype of glioblastoma.
Cheng W; Zhang C; Ren X; Jiang Y; Han S; Liu Y; Cai J; Li M; Wang K; Liu Y; Hu H; Li Q; Yang P; Bao Z; Wu A
J Neurosurg; 2017 Jan; 126(1):249-259. PubMed ID: 26967788
[TBL] [Abstract][Full Text] [Related]
10. Construction of an immune-related gene signature for the prognosis and diagnosis of glioblastoma multiforme.
Yu Z; Yang H; Song K; Fu P; Shen J; Xu M; Xu H
Front Oncol; 2022; 12():938679. PubMed ID: 35982954
[TBL] [Abstract][Full Text] [Related]
11. Identification of Iron Metabolism-Related Genes as Prognostic Indicators for Lower-Grade Glioma.
Xu S; Wang Z; Ye J; Mei S; Zhang J
Front Oncol; 2021; 11():729103. PubMed ID: 34568059
[TBL] [Abstract][Full Text] [Related]
12. A novel risk signature with 6 RNA binding proteins for prognosis prediction in patients with glioblastoma.
Huang QR; Li JW; Pan XB
Medicine (Baltimore); 2021 Dec; 100(48):e28065. PubMed ID: 35049227
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of oxidative stress-related lncRNA signatures in glioma reveals the discrepancy of prognostic and immune infiltration.
Shi Z; Wu Y; Zhuo Q; Zuo Y; Lin J; Shi H; Zhou H; Xu Z
Sci Rep; 2023 May; 13(1):7731. PubMed ID: 37173373
[TBL] [Abstract][Full Text] [Related]
14. GRN is a prognostic biomarker and correlated with immune infiltration in glioma: A study based on TCGA data.
Xu SM; Xiao HY; Hu ZX; Zhong XF; Zeng YJ; Wu YX; Li D; Song T
Front Oncol; 2023; 13():1162983. PubMed ID: 37091137
[TBL] [Abstract][Full Text] [Related]
15. SP140 inhibitor suppressing TRIM22 expression regulates glioma progress through PI3K/AKT signaling pathway.
Li X; Li G; Li L; Gao B; Niu X; Wang Y; Wang Z
Brain Behav; 2024 Mar; 14(3):e3465. PubMed ID: 38468469
[TBL] [Abstract][Full Text] [Related]
16. Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma.
Zhang M; Wang X; Chen X; Zhang Q; Hong J
Front Genet; 2020; 11():363. PubMed ID: 32351547
[TBL] [Abstract][Full Text] [Related]
17. Construction and validation of a risk model based on the key SNARE proteins to predict the prognosis and immune microenvironment of gliomas.
Yin L; Xu Y; Yin J; Cheng H; Xiao W; Wu Y; Ji D; Gao S
Front Mol Neurosci; 2023; 16():1304224. PubMed ID: 38115820
[TBL] [Abstract][Full Text] [Related]
18. The overexpression of GPX8 is correlated with poor prognosis in GBM patients.
Li S; Jiang X; Guan M; Zhang Y; Cao Y; Zhang L
Front Genet; 2022; 13():898204. PubMed ID: 36061208
[TBL] [Abstract][Full Text] [Related]
19. Interferon gamma-related gene signature based on anti-tumor immunity predicts glioma patient prognosis.
Zhang Z; Shen X; Tan Z; Mei Y; Lu T; Ji Y; Cheng S; Xu Y; Wang Z; Liu X; He W; Chen Z; Chen S; Lv Q
Front Genet; 2022; 13():1053263. PubMed ID: 36712869
[No Abstract] [Full Text] [Related]
20. Molecular and Clinicopathological Characterization of a Prognostic Immune Gene Signature Associated With MGMT Methylation in Glioblastoma.
Zhao L; Zhang J; Xuan S; Liu Z; Wang Y; Zhao P
Front Cell Dev Biol; 2021; 9():600506. PubMed ID: 33614641
[No Abstract] [Full Text] [Related]
[Next] [New Search]
